Teizo Yoshimura

15PUBLICATIONS
22CO-AUTHORS
AutoimmunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 27, 2026
Host-Fungus Interactions Link Autoimmune and Immune-Mediated Inflammatory Diseases to Gastrointestinal Cancer: Lessons from KA/KA and Card9-/- Mouse Models.

|Sep 27, 2026
SPRED2 Negatively Regulates CD8+ T Cell-Mediated Antitumor Immunity in Breast Cancer.

|Jun 12, 2026
Advances in Immune Checkpoint Inhibitors for Cancer Treatment.

|Apr 14, 2026
CXCR2-Dependent Infiltration of Tumor-Associated Neutrophils Is Linked to Enhanced CD8+ T Cell Effector Function and Reduced Lung Metastasis in 4T1 Breast Cancer.

Tiantian Li, Teizo Yoshimura, Miao Tian

|Oct 29, 2025
Neurofibromin Encoded by the Neurofibromatosis Type 1 (NF1) Gene Promotes the Membrane Translocation of SPRED2, Thereby Inhibiting the ERK Pathway in Breast Cancer Cells.

Nang Thee Su Pwint, Chunning Li, Tong Gao

|Jun 19, 2024
SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes.

Tianyi Wang, Tong Gao, Masayoshi Fujisawa

Pageof 3

Frequent Collaborators

6 joint publications

Toshiaki Ohara

6 joint publications

Akihiro Matsukawa

3 joint publications

Masakiyo Sakaguchi

2 joint publications

Masayoshi Fujisawa